FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034983118> ?p ?o ?g. }

• W2034983118 endingPage "21129" @default.
• W2034983118 startingPage "21124" @default.
• W2034983118 abstract "The PI3K pathway is genetically altered in excess of 70% of breast cancers, largely through PIK3CA mutation and HER2 amplification. Preclinical studies have suggested that these subsets of breast cancers are particularly sensitive to PI3K inhibitors; however, the reasons for this heightened sensitivity are mainly unknown. We investigated the signaling effects of PI3K inhibition in PIK3CA mutant and HER2 amplified breast cancers using PI3K inhibitors currently in clinical trials. Unexpectedly, we found that in PIK3CA mutant and HER2 amplified breast cancers sensitive to PI3K inhibitors, PI3K inhibition led to a rapid suppression of Rac1/p21-activated kinase (PAK)/protein kinase C-RAF (C-RAF)/ protein kinase MEK (MEK)/ERK signaling that did not involve RAS. Furthermore, PI3K inhibition led to an ERK-dependent up-regulation of the proapoptotic protein, BIM, followed by induction of apoptosis. Expression of a constitutively active form of Rac1 in these breast cancer models blocked PI3Ki-induced down-regulation of ERK phosphorylation, apoptosis, and mitigated PI3K inhibitor sensitivity in vivo. In contrast, protein kinase AKT inhibitors failed to block MEK/ERK signaling, did not up-regulate BIM, and failed to induce apoptosis. Finally, we identified phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 (P-Rex1) as the PI(3,4,5)P3-dependent guanine exchange factor for Rac1 responsible for regulation of the Rac1/C-RAF/MEK/ERK pathway in these cells. The expression level of P-Rex1 correlates with sensitivity to PI3K inhibitors in these breast cancer cell lines. Thus, PI3K inhibitors have enhanced activity in PIK3CA mutant and HER2 amplified breast cancers in which PI3K inhibition down-regulates both the AKT and Rac1/ERK pathways. In addition, P-Rex1 may serve as a biomarker to predict response to single-agent PI3K inhibitors within this subset of breast cancers." @default.
• W2034983118 created "2016-06-24" @default.
• W2034983118 creator A5006532159 @default.
• W2034983118 creator A5017882443 @default.
• W2034983118 creator A5039591761 @default.
• W2034983118 creator A5040093136 @default.
• W2034983118 creator A5040148157 @default.
• W2034983118 creator A5041913040 @default.
• W2034983118 creator A5054248424 @default.
• W2034983118 creator A5060699951 @default.
• W2034983118 creator A5072389805 @default.
• W2034983118 creator A5075869265 @default.
• W2034983118 creator A5087308492 @default.
• W2034983118 creator A5088194700 @default.
• W2034983118 date "2013-12-10" @default.
• W2034983118 modified "2023-10-18" @default.
• W2034983118 title "PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1" @default.
• W2034983118 cites W1560450744 @default.
• W2034983118 cites W1965626427 @default.
• W2034983118 cites W1967913221 @default.
• W2034983118 cites W1977267072 @default.
• W2034983118 cites W1987127207 @default.
• W2034983118 cites W1991166678 @default.
• W2034983118 cites W2001999652 @default.
• W2034983118 cites W2004691500 @default.
• W2034983118 cites W2006104341 @default.
• W2034983118 cites W2010601523 @default.
• W2034983118 cites W2015512041 @default.
• W2034983118 cites W2029293132 @default.
• W2034983118 cites W2030733555 @default.
• W2034983118 cites W2042264070 @default.
• W2034983118 cites W2046584993 @default.
• W2034983118 cites W2059299508 @default.
• W2034983118 cites W2065620201 @default.
• W2034983118 cites W2071549499 @default.
• W2034983118 cites W2074075635 @default.
• W2034983118 cites W2105889692 @default.
• W2034983118 cites W2108541764 @default.
• W2034983118 cites W2125789330 @default.
• W2034983118 cites W2131526143 @default.
• W2034983118 cites W2141393790 @default.
• W2034983118 cites W2142579731 @default.
• W2034983118 cites W2146024986 @default.
• W2034983118 cites W2146029333 @default.
• W2034983118 cites W2148950251 @default.
• W2034983118 cites W2152277972 @default.
• W2034983118 cites W2155228605 @default.
• W2034983118 cites W2162946128 @default.
• W2034983118 cites W2165280661 @default.
• W2034983118 cites W2168695856 @default.
• W2034983118 cites W2171771895 @default.
• W2034983118 cites W2243971624 @default.
• W2034983118 cites W2589396808 @default.
• W2034983118 cites W41026852 @default.
• W2034983118 doi "https://doi.org/10.1073/pnas.1314124110" @default.
• W2034983118 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3876254" @default.
• W2034983118 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24327733" @default.
• W2034983118 hasPublicationYear "2013" @default.
• W2034983118 type Work @default.
• W2034983118 sameAs 2034983118 @default.
• W2034983118 citedByCount "170" @default.
• W2034983118 countsByYear W20349831182014 @default.
• W2034983118 countsByYear W20349831182015 @default.
• W2034983118 countsByYear W20349831182016 @default.
• W2034983118 countsByYear W20349831182017 @default.
• W2034983118 countsByYear W20349831182018 @default.
• W2034983118 countsByYear W20349831182019 @default.
• W2034983118 countsByYear W20349831182020 @default.
• W2034983118 countsByYear W20349831182021 @default.
• W2034983118 countsByYear W20349831182022 @default.
• W2034983118 countsByYear W20349831182023 @default.
• W2034983118 crossrefType "journal-article" @default.
• W2034983118 hasAuthorship W2034983118A5006532159 @default.
• W2034983118 hasAuthorship W2034983118A5017882443 @default.
• W2034983118 hasAuthorship W2034983118A5039591761 @default.
• W2034983118 hasAuthorship W2034983118A5040093136 @default.
• W2034983118 hasAuthorship W2034983118A5040148157 @default.
• W2034983118 hasAuthorship W2034983118A5041913040 @default.
• W2034983118 hasAuthorship W2034983118A5054248424 @default.
• W2034983118 hasAuthorship W2034983118A5060699951 @default.
• W2034983118 hasAuthorship W2034983118A5072389805 @default.
• W2034983118 hasAuthorship W2034983118A5075869265 @default.
• W2034983118 hasAuthorship W2034983118A5087308492 @default.
• W2034983118 hasAuthorship W2034983118A5088194700 @default.
• W2034983118 hasBestOaLocation W20349831181 @default.
• W2034983118 hasConcept C184235292 @default.
• W2034983118 hasConcept C185592680 @default.
• W2034983118 hasConcept C2779717556 @default.
• W2034983118 hasConcept C2781249067 @default.
• W2034983118 hasConcept C502942594 @default.
• W2034983118 hasConcept C57074206 @default.
• W2034983118 hasConcept C62478195 @default.
• W2034983118 hasConcept C75217442 @default.
• W2034983118 hasConcept C86554907 @default.
• W2034983118 hasConcept C86803240 @default.
• W2034983118 hasConcept C95444343 @default.
• W2034983118 hasConceptScore W2034983118C184235292 @default.
• W2034983118 hasConceptScore W2034983118C185592680 @default.

• next